Allergy and immunology


Basic research

Cardiovascular medicine

Complementary medicine and alternative therapies

Critical care / intensive care

Dentistry / oral medicine


Emergency medicine




Evidence-based medicine



Geriatric medicine / aging

Haematology / blood transfusion

Health economics

Health policy

History of medicine

Infectious diseases

Internal medicine

Laboratory medicine

Medical education

Medical informatics



Nutrition and metabolism

Obstetrics and gynaecology

Occupational and environmental medicine



Organisation of health care

Otolaryngology / head and neck surgery


Palliative care


Patient-physician relationship

Pharmacology and therapeutics

Primary care, family medicine

Psychiatry and psychotherapy


Public health

Quality of care


Rehabilitation medicine

Renal medicine

Respiratory medicine


Sexual medicine

Sports medicine

Statistics and research methods



Travel medicine


Ops! No article found. Reset filter

Evolution of gynaecologists’ practices regarding the implementation of Swiss legislation on maternity protection at work between 2008 and 2017

Original article
Abderhalden-Zellweger A, Mediouni Z, Probst I, Politis Mercier MP, Danuser B, Wild P, Chiarini B, Hale ML, Krief P
Swiss Med Wkly. 2021;151:w20537

In accordance with the International Labour Organization’s Maternity Protection Convention (No. 183) and European Union Directive 92/857CEE (1992), Switzerland’s Labour Law and its Maternity Protection Ordinance (OProMa) aim to protect the health of pregnant employees and their future children while enabling them to pursue their working activities. Gynaecologists-obstetricians have a key role in this legislation, particularly through the prescription of preventive leave for patients who would otherwise face dangerous or arduous tasks in the absence of an adequate risk analysis or suitable protective measures. However, international and national literature suggests that gynaecologists-obstetricians may encounter difficulties in fulfilling their role. 

Remote self-assessment follow-up for medical termination of pregnancy at Geneva University Hospitals: an insight into its acceptability, success rate and costs

Original article
Vanetti A, Catarino R, Yaron M
Swiss Med Wkly. 2021;151:w20531

Remote follow-up based on self-assessment plus a telephone call with a healthcare provider is a safe and reliable method for assessing the success of medical termination of pregnancy and can lead to an important reduction in costs. The aim of the study was to analyse its efficacy, acceptability and associated costs. A remote follow-up procedure is an acceptable and less costly alternative to hospital-based follow-up with a higher rate of acceptability and adherence by the studied population.

The role of sFlt1/PlGF ratio in the assessment of preeclampsia and pregnancy-related hypertensive disorders

Review article: Biomedical intelligence
Baert J, McCarey C, Berkane N, Martinez de Tejada B, Vial Y, Rieder W
Swiss Med Wkly. 2021;151:w20533

For many years, research tried to evaluate the significance of serum biomarkers as early indicators of preeclampsia. Among many, the sFlt-1/PlGF ratio, given its performance, aroused the greatest interest. This article reviews current knowledge on the subject, focusing on a Swiss perspective.

Losing your virginity safely? A Swiss national survey

Original article
Meuwly M, Auderset D, Suris JC, Barrense-Dias Y
Swiss Med Wkly. 2021;151:w20509

Contraception is generally used at first intercourse in Switzerland. Improvements can still be made concerning contraception use in the most vulnerable social strata such as low income families or foreign status.

Single embryo transfer in all infertile couples treated with assisted reproduction produces excellent results and avoids multiple births

Original article
De Geyter C
Swiss Med Wkly. 2021;151:w20499

The consequent adoption of a single embryo transfer significantly reduced the incidence of multiple births in the department of obstetrics and the number of prematurely born infants resulting from multiple pregnancies in the department of neonatology. Universal elective single embryo transfer is feasible in Switzerland, benefits infertile couples treated with assisted reproductive technology and reduces the number of multiple births in obstetrics and of newborn children hospitalised into neonatal care.

Gestational trophoblastic disease in Switzerland: retrospective study of the impact of a regional reference centre

Original article
Fehlmann A, Benkortbi K, Rosseel G, Meyer-Hamme U, Tille JC, Sloan-Bena F, Paoloni-Giacobino A, Rougemont AL, Bodmer A, Botsikas D, Mathevet P, Petignat P, Undurraga Malinverno M
Swiss Med Wkly. 2021;151:w20406

The European Society of Medical Oncology recommends that countries should have reference centres to provide adequate diagnosis and treatment of gestational trophoblastic disease. This study reflects the activity of the Swiss trophoblastic disease centre from the French-speaking part of Switzerland created in 2009, and its role as local and national reference centre, in terms of global health, for women with gestational trophoblastic disease.

Use of valproate in pregnancy and in women of childbearing age between 2014 and 2018 in Switzerland: a retrospective analysis of Swiss healthcare claims data

Original article
Spoendlin J, Blozik E, Graber S, Rauch M, Marxer C, Rüegg S, Meier C, Winterfeld U, Panchaud A
Swiss Med Wkly. 2021;151:w20386

As in most other European countries, the use of valproate in women of childbearing age in this study was higher than what the authors estimated to be indicated. This study demonstrates the value of electronic claims databases in the evaluation of drug exposure during pregnancy.

Maternal mortality in Switzerland 2005–2014

Original article
Perotto L, Zimmermann R, Quack Lötscher KC
Swiss Med Wkly. 2020;150:w20345

The trend of reducing direct maternal mortality as well as lethality after caesarean section continues. Haemorrhage is still the leading cause of direct maternal mortality. Indirect maternal mortality is increasing and specifically suicides need special attention.

Labour outcomes with defibulation at delivery in immigrant Somali and Sudanese women with type III female genital mutilation/cutting

Original article
Rouzi AA, Berg RC, Al-Wassia H, Alamoudi R, Hariri W, Sindi G, Almansouri N, Sahly N
Swiss Med Wkly. 2020;150:w20326

Defibulation at delivery is an effective minor surgical procedure that should be in the armamentarium of the healthcare providers managing women with type III female genital mutilation/cutting.

Medical-ethical recommendations: preimplantation genetic testing PGT

Special article
Swiss Academy of Medical Sciences
Swiss Med Wkly. 2020;150:w20298

The recommendations of the Swiss Academy of Medical Sciences (SAMS) are designed to draw attention, from an ethical perspective, to important aspects of the PGT counselling and decision-making situation, and to promote ethical awareness in the performance of PGT. In addition, they discuss how, for example, surplus information should be managed.

Verpassen Sie keinen Artikel!